Atrial fibrillation

The Lancet

Volumn 379, Issue 9816, 2012, Pages 648-661

  Lip, Gregory Y H ^a   Tse, Hung Fat ^b   Lane, Deirdre A ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b QUEEN MARY HOSPITAL   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

AMIODARONE; ANTICOAGULANT AGENT; DIGOXIN; DILTIAZEM; DOFETILIDE; DRONEDARONE; ESMOLOL; FLECAINIDE; IBUTILIDE; METOPROLOL; PROPAFENONE; PROPRANOLOL; VERAPAMIL; VERNAKALANT;

ABLATION THERAPY; ANTICOAGULANT THERAPY; CARDIOVASCULAR RISK; CARDIOVERSION; CATHETER ABLATION; COMORBIDITY; CONFERENCE PAPER; CONGESTIVE HEART FAILURE; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DRUG HYPERSENSITIVITY; ELECTROCARDIOGRAM; HEART ATRIUM APPENDAGE; HEART ATRIUM FIBRILLATION; HEART LEFT VENTRICLE FAILURE; HEART PACING; HUMAN; HYPERTENSION; OBESITY; PRIORITY JOURNAL; RISK ASSESSMENT; SCREENING; SINUS RHYTHM; SMOKING; STROKE; THORAX RADIOGRAPHY; THORAX SURGERY; THROMBOSIS PREVENTION; TREATMENT DURATION;

EID: 84857236286     PISSN: 01406736     EISSN: 1474547X     Source Type: Journal    
DOI: 10.1016/S0140-6736(11)61514-6     Document Type: Conference Paper

References (134)

1. Y Miyasaka, ME Barnes, BJ Gersh et al. Secular trends in incidence of atrial fibrillation in Olmsted County, Minnesota, 1980 to 2000, and implications on the projections for future prevalence Circulation 114 2006 119 125 (Pubitemid 44420743)
2. DM Lloyd-Jones, TJ Wang, EP Leip et al. Lifetime risk for development of atrial fibrillation: the Framingham Heart Study Circulation 110 2004 1042 1046 (Pubitemid 39319000)
3. J Heeringa, DA van der Kuip et al. Prevalence, incidence and lifetime risk of atrial fibrillation: the Rotterdam study Eur Heart J 27 2006 949 953
4. AJ Camm, P Kirchhof, GY Lip et al. Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC) Eur Heart J 31 2010 2369 2429
5. GY Lip, H-F Tse Management of atrial fibrillation Lancet 370 2007 604 618 (Pubitemid 47248681)
6. GYH Lip, HS Lim Atrial fibrillation and stroke prevention Lancet Neurol 6 2007 981 993 (Pubitemid 47566414)
7. FD Hobbs, DA Fitzmaurice, J Mant et al. A randomised controlled trial and cost-effectiveness study of systematic screening (targeted and total population screening) versus routine practice for the detection of atrial fibrillation in people aged 65 and over. The SAFE study Health Technol Assess 9 2005 iii iiv ix-x, 1-74.
8. AY Shen, R Contreras, S Sobnosky et al. Racial/ethnic differences in the prevalence of atrial fibrillation among older adults - a cross-sectional study J Natl Med Assoc 102 2010 906 913
9. D Kaireviciute, A Aidietis, GY Lip Atrial fibrillation following cardiac surgery: clinical features and preventative strategies Eur Heart J 30 2009 410 425
10. J Liao, Z Khalid, C Scallan, C Morillo, M O'Donnell Noninvasive cardiac monitoring for detecting paroxysmal atrial fibrillation or flutter after acute ischemic stroke: a systematic review Stroke 38 2007 2935 2940 (Pubitemid 350035686)
11. RR Huxley, FL Lopez, AR Folsom et al. Absolute and attributable risks of atrial fibrillation in relation to optimal and borderline risk factors: the Atherosclerosis Risk in Communities (ARIC) study Circulation 123 2011 1501 1508
12. S Nattel, B Burstein, D Dobrev Atrial remodeling and atrial fibrillation: mechanisms and implications Circ Arrhythm Electrophysiol 1 2008 62 73
13. RB Schnabel, LM Sullivan, D Levy et al. Development of a risk score for atrial fibrillation (Framingham Heart Study): a community-based cohort study Lancet 373 2009 739 745
14. AM Chamberlain, SK Agarwal, AR Folsom et al. A clinical risk score for atrial fibrillation in a biracial prospective cohort (from the Atherosclerosis Risk in Communities [ARIC] study) Am J Cardiol 107 2011 85 91
15. CS Fox, H Parise, RB D'Agostino Sr et al. Parental atrial fibrillation as a risk factor for atrial fibrillation in offspring JAMA 291 2004 2851 2855 (Pubitemid 38747806)
16. DO Arnar, S Thorvaldsson, TA Manolio et al. Familial aggregation of atrial fibrillation in Iceland Eur Heart J 27 2006 708 712
17. JD Robert, MH Gollob Impact of genetic discoveries on the classification of lone atrial fibrillation J Am Coll Cardiol 55 2010 705 712
18. SA Lubitz, C Ozcan, JW Magnani, S Kääb, EJ Benjamin, PT Ellinor Genetics of atrial fibrillation: implications for future research directions and personalized medicine Circ Arrhythm Electrophysiol 3 2010 291 299
19. S Gretarsdottir, G Thorleifsson, A Manolescu et al. Risk variants for atrial fibrillation on chromosome 4q25 associate with ischemic stroke Ann Neurol 64 2008 402 409
20. DF Gudbjartsson, H Holm, S Gretarsdottir et al. A sequence variant in ZFHX3 on 16q22 associates with atrial fibrillation and ischemic stroke Nat Genet 41 2009 876 878
21. D Husser, V Adams, C Piorkowski, G Hindricks, A Bollmann Chromosome 4q25 variants and atrial fibrillation recurrence after catheter ablation J Am Coll Cardiol 55 2010 747 753
22. SA Lubitz, X Yin, JD Fontes et al. Association between familial atrial fibrillation and risk of new-onset atrial fibrillation JAMA 304 2010 2263 2269
23. GM Marcus, A Alonso, CA Peralta for the Candidate-Gene Association Resource (CARe) Study European ancestry as a risk factor for atrial fibrillation in African Americans Circulation 122 2010 2009 2015
24. GL Botto, L Padeletti, M Santini et al. Presence and duration of atrial fibrillation detected by continuous monitoring: crucial implications for the risk of thromboembolic events J Cardiovasc Electrophysiol 20 2009 241 248
25. A Capucci, M Santini, L Padeletti et al. Monitored atrial fibrillation duration predicts arterial embolic events in patients suffering from bradycardia and atrial fibrillation implanted with antitachycardia pacemakers J Am Coll Cardiol 46 2005 1913 1920 (Pubitemid 41579816)
26. TV Glotzer, EG Daoud, DG Wyse et al. The relationship between daily atrial tachyarrhythmia burden from implantable device diagnostics and stroke risk. The TRENDS Study Circ Arrhythmia Electrophysiol 2 2009 474 480
27. G Hindricks, E Pokushalov, L Urban for the XPECT Trial Investigators Performance of a new leadless implantable cardiac monitor in detecting and quantifying atrial fibrillation: results of the XPECT trial Circ Arrhythm Electrophysiol 3 2010 141 147
28. G Boriani, GL Botto, L Padeletti et al. Improving stroke risk stratification using the CHADS2 and CHA2DS2-VASc risk scores in paroxysmal atrial fibrillation patients by continuous arrhythmia burden monitoring Stroke 42 2011 1768 1770
29. National Collaborating Centre for Chronic Conditions Atrial fibrillation: national clinical guideline for management in primary and secondary care 2006 Royal College of Physicians London
30. T Watson, E Shantsila, GY Lip Mechanisms of thrombogenesis in atrial fibrillation: Virchow's triad revisited Lancet 373 2009 155 166
31. C Steger, A Pratter, M Martinek-Bregel et al. Stroke patients with atrial fibrillation have a worse prognosis than patients without: data from the Austrian Stroke registry Eur Heart J 25 2004 1734 1740 (Pubitemid 39286639)
32. Stroke Risk in Atrial Fibrillation Working Group Independent predictors of stroke in patients with atrial fibrillation: a systematic review Neurology 69 2007 546 554
33. M Hughes, GY Lip Guideline Development Group National Clinical Guideline for Management of Atrial Fibrillation in Primary and Secondary Care National Institute for Health and Clinical Excellence Stroke and thromboembolism in atrial fibrillation: a systematic review of stroke risk factors, risk stratification schema and cost effectiveness data Thromb Haemost 99 2008 295 304 (Pubitemid 351230959)
34. Atrial Fibrillation Investigators Echocardiographic predictors of stroke in patients with atrial fibrillation. A prospective study of 1066 patients from three clinical trials Arch Intern Med 158 1998 1316 1320
35. MC Fang, AS Go, Y Chang, L Borowsky, NK Pomernacki, DE Singer for the ATRIA Study Group Comparison of risk stratification schemes to predict thromboembolism in people with non-valvular atrial fibrillation J Am Coll Cardiol 51 2008 810 815 (Pubitemid 351253746)
36. L Baruch, BF Gage, J Horrow et al. Can patients at elevated risk of stroke treated with anticoagulants be further risk stratified? Stroke 38 2007 2459 2463 (Pubitemid 47329622)
37. TP van Staa, E Setakis, GL Di Tanna, DA Lane, GY Lip A comparison of risk stratification schemes for stroke in 79,884 atrial fibrillation patients in general practice J Thromb Haemost 9 2011 39 48
38. IM Ogilvie, N Newton, SA Welner, W Cowell, GY Lip Underuse of oral anticoagulants in atrial fibrillation: a systematic review Am J Med 123 2010 638 645
39. I Ahrens, GY Lip, K Peter New oral anticoagulant drugs in cardiovascular disease Thromb Haemost 104 2010 49 60
40. Y Wan, C Heneghan, R Perera et al. Anticoagulation control and prediction of adverse events in patients with atrial fibrillation: a systematic review Circ Cardiovasc Qual Outcomes 1 2008 84 91
41. GY Lip, JL Halperin Improving stroke risk stratification in atrial fibrillation Am J Med 123 2010 484 488
42. V Fuster, LE Ryden, DS Cannom Task Force on Practice Guidelines American College of Cardiology/American Heart Association; Committee for Practice Guidelines European Society of Cardiology; European Heart Rhythm Association; Heart Rhythm Society ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation-executive summary: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients with Atrial Fibrillation) Eur Heart J 27 2006 1979 2030 (Pubitemid 44313588)
43. MC Fang, DE Singer, Y Chang, EM Hylek, LE Henault, NG Jensvold, AS Go Gender differences in the risk of ischemic stroke and peripheral embolism in atrial fibrillation: the AnTicoagulation and Risk factors In Atrial fibrillation (ATRIA) study Circulation 112 2005 1687 1691 (Pubitemid 41368143)
44. J Friberg, H Scharling, N Gadsbøll, T Truelsen, GB Jensen Copenhagen City Heart Study Comparison of the impact of atrial fibrillation on the risk of stroke and cardiovascular death in women versus men (The Copenhagen City Heart Study) Am J Cardiol 94 2004 889 894 (Pubitemid 39359174)
45. LH Rasmussen, TB Larsen, KM Due, A Tjønneland, KM Overvad, GYH Lip Impact of vascular disease in predicting stroke, and death in patients with atrial fibrillation: the Danish Diet, Cancer and Health (DCH) cohort study Thromb Haemost 9 2011 1301 1307
46. BF Gage, AD Waterman, W Shannon, M Boechler, MW Rich, MJ Radford Validation of clinical classification schemes for predicting stroke: Results from the national registry of atrial fibrillation JAMA 285 2001 2864 2870 (Pubitemid 32537350)
47. 2 score for stroke risk stratification in atrial fibrillation-friend or foe? Thromb Haemost 104 2010 45 48
48. JB Olesen, GY Lip, ML Hansen et al. Validation of risk stratification schemes for predicting stroke and thromboembolism in patients with atrial fibrillation: nationwide cohort study BMJ 342 2011 d124
49. RG Hart, LA Pearce, MI Aguilar Meta-analysis: antithrombotic therapy to prevent stroke in patients who have non-valvular atrial fibrillation Ann Intern Med 146 2007 857 867 (Pubitemid 351650486)
50. GY Lip, R Nieuwlaat, R Pisters, DA Lane, HJ Crijns Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the Euro Heart survey on atrial fibrillation Chest 137 2010 263 272
51. GY Lip, L Frison, JL Halperin, DA Lane Identifying patients at high risk for stroke despite anticoagulation: a comparison of contemporary stroke risk stratification schemes in an anticoagulated atrial fibrillation cohort Stroke 41 2010 2731 2738
52. D Poli, GY Lip, E Antonucci, E Grifoni, D Lane Stroke risk stratification in a "real-world" elderly anticoagulated atrial fibrillation population J Cardiovasc Electrophysiol 22 2011 25 30
53. M Hughes, GY Lip for the Guideline Development Group for the NICE national clinical guideline for management of atrial fibrillation in primary and secondary care Risk factors for anticoagulation-related bleeding complications in patients with atrial fibrillation: a systematic review QJM 100 2007 599 607 (Pubitemid 47543414)
54. DA Garcia, RD Lopes, EM Hylek New-onset atrial fibrillation and warfarin initiation: high risk periods and implications for new antithrombotic drugs Thromb Haemost 104 2010 1099 1105
55. GYH Lip, F Andreotti, L Fauchier et al. Bleeding risk assessment and management in atrial fibrillation patients: a position document from the European Heart Rhythm Association, endorsed by the European Society of Cardiology Working Group on Thrombosis Europace 13 2011 723 746
56. R Pisters, DA Lane, R Nieuwlaat, CB de Vos, HJ Crijns, GY Lip A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: the Euro Heart Survey Chest 138 2010 1093 1100
57. GY Lip, L Frison, JL Halperin, DA Lane Comparative validation of a novel risk score for predicting bleeding risk in anticoagulated patients with atrial fibrillation: the HAS-BLED (Hypertension, Abnormal Renal/Liver Function, Stroke, Bleeding History or Predisposition, Labile INR, Elderly, Drugs/Alcohol Concomitantly) score J Am Coll Cardiol 57 2011 173 180
58. JA Cairns, S Connolly, S McMurtry, M Stephenson Talajic M; CCS Atrial Fibrillation Guidelines Committee Canadian Cardiovascular Society atrial fibrillation guidelines 2010: prevention of stroke and systemic thromboembolism in atrial fibrillation and flutter Can J Cardiol 27 2011 74 90
59. (2)-VASc and HAS-BLED scores for thromboprophylaxis in atrial fibrillation Am J Med 124 2011 111 114
60. K Lakshminarayan, CA Solid, AJ Collins, DC Anderson, CA Herzog Atrial fibrillation and stroke in the general Medicare population: a 10-year perspective (1992 to 2002) Stroke 37 2006 1969 1974 (Pubitemid 44309888)
61. Stroke prevention in atrial fibrillation investigators A differential effect of aspirin in prevention of stroke on atrial fibrillation J Stroke Cerebrovasc Dis 3 1993 181 188
62. H Sato, K Ishikawa, A Kitabatake for the Japan Atrial Fibrillation Stroke Trial Group Low-dose aspirin for prevention of stroke in low-risk patients with atrial fibrillation: Japan Atrial Fibrillation Stroke Trial Stroke 37 2006 447 451 (Pubitemid 43732003)
63. The ACTIVE Writing Group on behalf of the ACTIVE Investigators Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events (ACTIVE W): a randomised controlled trial Lancet 367 2006 1903 1912
64. SJ Connolly, J Pogue, RG Hart for the ACTIVE Investigators Effect of clopidogrel added to aspirin in patients with atrial fibrillation N Engl J Med 360 2009 2066 2078
65. GY Lip, K Huber, F Andreotti for the European Society of Cardiology Working Group on Thrombosis Management of antithrombotic therapy in atrial fibrillation patients presenting with acute coronary syndrome and/or undergoing percutaneous coronary intervention/stenting Thromb Haemost 103 2010 13 28
66. C van Walraven, RG Hart, S Connolly et al. Effect of age on stroke prevention therapy in patients with atrial fibrillation: the atrial fibrillation investigators Stroke 40 2009 1410 1416
67. J Mant, FDR Hobbs, K Fletcher on behalf of the BAFTA investigators and the Midland Research Practices Network (MidReC) Warfarin versus aspirin for stroke prevention in an elderly community population with atrial fibrillation (the Birmingham Atrial Fibrillation Treatment of the Aged Study, BAFTA): a randomised controlled trial Lancet 370 2007 493 503 (Pubitemid 47212371)
68. A Rash, T Downes, R Portner, WW Yeo, N Morgan, KS Channer A randomised controlled trial of warfarin versus aspirin for stroke prevention in octogenarians with atrial fibrillation (WASPO) Age Ageing 36 2007 151 156 (Pubitemid 46455393)
69. MH Eckman, DE Singer, J Rosand, SM Greenberg Moving the tipping point: the decision to anticoagulate patients with atrial fibrillation Circ Cardiovasc Qual Outcomes 4 2011 14 21
70. JB Olesen, GY Lip, J Lindhardsen et al. Risks of thromboembolism and bleeding with thromboprophylaxis in patients with atrial fibrillation: a net clinical benefit analysis using a 'real world' nationwide cohort study Thromb Haemost 2011 10.1160/TH11-05-0364 published online July 20.
71. M Man Son Hing, Laupacis, A O'Connor et al. Warfarin for atrial fibrillation: the patient's perspective Arch Intern Med 156 1996 1841 1848 (Pubitemid 26295230)
72. A Howitt, D Armstrong Implementing evidence based medicine in general practice: audit and qualitative study of antithrombotic treatment for atrial fibrillation BMJ 318 1999 1324 1327 (Pubitemid 29219046)
73. J Protheroe, T Fahey, AA Montgomery, TJ Peters The impact of patients' preferences on the treatment of atrial fibrillation: observational study of patient based decision analysis BMJ 320 2000 1380 1384 (Pubitemid 30261119)
74. RG Thomson, MP Eccles, IN Steen et al. A patient decision aid to support shared decision-making on antithrombotic treatment of patients with atrial fibrillation: randomised controlled trial Qual Saf Health Care 16 2007 216 223 (Pubitemid 46972867)
75. E Aliot, G Briethardt, J Brugada for the Atrial Fibrillation AWareness And Risk Education (AF AWARE) group [comprising the Atrial Fibrillation Association (AFA) the European Heart Rhythm Association (EHRA) Stroke Alliance for Europe (SAFE) and the World Heart Federation (WHF)] An international survey of physician and patient understanding, perception, and attitudes to atrial fibrillation and its contribution to cardiovascular disease morbidity and mortality Europace 12 2010 626 633
76. R Fuller, N Dudley, J Blacktop Avoidance hierarchies and preferences for anticoagulation- semi-qualitative analysis of older patients' views about stroke prevention and the use of warfarin Age Ageing 33 2004 608 611 (Pubitemid 39504295)
77. PJ Devereaux, DR Anderson, MJ Gardner et al. Differences between perspectives of physicians and patients on anticoagulation in patients with atrial fibrillation; observational study BMJ 323 2001 1 7
78. GYH Lip, G Agnelli, AA Thach, E Knight, D Rost, MJ Tangelder Oral anticoagulation in atrial fibrillation: a pan-European patient survey Eur J Intern Med 18 2007 202 208 (Pubitemid 46628758)
79. A Holbrook, R Labiris, CH Goldsmith, K Ota, S Harb, RJ Sebaldt Influence of decision aids on patient preferences for anticoagulant therapy: a randomised trial Can Med Assoc J 176 2007 1583 1587 (Pubitemid 46868606)
80. SJ Connolly, MD Ezekowitz, S Yusuf for the RE-LY Steering Committee and Investigators Dabigatran versus warfarin in patients with atrial fibrillation N Engl J Med 361 2009 1139 1151
81. NS Roskell, GY Lip, H Noack, A Clemens, JM Plumb Treatments for stroke prevention in atrial fibrillation: a network meta-analysis and indirect comparisons versus dabigatran etexilate Thromb Haemost 104 2010 1106 1115
82. SJ Connolly, J Eikelboom, C Joyner for the AVERROES Steering Committee and Investigators Apixaban in patients with atrial fibrillation N Engl J Med 364 2011 806 817
83. MR Patel, KW Mahaffey, J Garg ROCKET AF Investigators Rivaroxaban versus warfarin in nonvalvular atrial fibrillation N Engl J Med 365 2011 883 891
84. CB Granger, JH Alexander, JJ McMurray for the ARISTOTLE Committees and Investigators Apixaban versus warfarin in patients with atrial fibrillation N Engl J Med 365 2011 981 992
85. CT Ruff, RP Giugliano, EM Antman et al. Evaluation of the novel factor Xa inhibitor edoxaban compared with warfarin in patients with atrial fibrillation: design and rationale for the Effective aNticoaGulation with factor xA next GEneration in Atrial Fibrillation-Thrombolysis In Myocardial Infarction study 48 (ENGAGE AF-TIMI 48) Am Heart J 160 2010 635 641
86. KA Glatter, PC Dorostkar, Y Yang et al. Electrophysiological effects of ibutilide in patients with accessory pathways Circulation 104 2001 1933 1939 (Pubitemid 32983237)
87. SM Simonian, S Lotfipour, C Wall, MI Langdorf Challenging the superiority of amiodarone for rate control in Wolff-Parkinson-White and atrial fibrillation Intern Emerg Med 5 2010 421 426
88. D Dobrev, S Nattel New antiarrhythmic drugs for treatment of atrial fibrillation Lancet 375 2010 1212 1223
89. AJ Camm, A Capucci, S Hohnloser et al. A randomized active-controlled study comparing the efficacy and safety of vernakalant to amiodarone in recent onset atrial fibrillation J Am Coll Cardiol 57 2011 313 321
90. SH Hohnloser, K-H Kuck, J Lilienthal for the PIAF Investigators Rhythm or rate control in atrial fibrillation - Pharmacological Intervention in Atrial Fibrillation (PIAF): a randomised trial Lancet 356 2000 1789 1794
91. AFFIRM Investigators A comparison of rate control and rhythm control in patients with atrial fibrillation N Engl J Med 347 2002 1825 1833
92. IC van Gelder, VE Hagens, HA Bosker et al. A comparison of rate control and rhythm control in patients with recurrent persistent atrial fibrillation N Engl J Med 347 2002 1834 1840 (Pubitemid 35417774)
93. J Carlsson, S Miketic, J Windeler the STAF Investigators Randomized trial of rate-control versus rhythm-control in persistent atrial fibrillation J Am Coll Cardiol 41 2003 1690 1696
94. G Opolski, A Torbicki, DA Kosior et al. Rate control vs. rhythm control in patients with non-valvular persistent atrial fibrillation: the results of the Polish How to Treat Chronic Atrial Fibrillation (HOT CAFE) study Chest 126 2004 476 486 (Pubitemid 39093433)
95. S Ogawa, T Yamashita, T Yamazaki et al. Optimal treatment strategy for patients with paroxysmal atrial fibrillation: J-RHYTHM Study Circ J 73 2009 242 248
96. D Roy, M Talajic, S Nattel et al. Rhythm control versus rate control for atrial fibrillation and heart failure N Engl J Med 358 2008 2667 2677 (Pubitemid 351860859)
97. AM Gillis, A Verma, M Talajic, S Nattel, P Dorian CCS Atrial Fibrillation Guidelines Committee Canadian Cardiovascular Society atrial fibrillation guidelines 2010: rate and rhythm management Can J Cardiol 27 2011 47 59
98. IC van Gelder, HF Groenveld, HJ Crijns et al. Lenient versus strict rate control in patients with atrial fibrillation N Engl J Med 362 2010 1363 1373
99. LS Wann, AB Curtis, CT January 2011 Writing Group Members V Fuster, LE Rydén, DS Cannom 2006 Writing Committee Members AK Jacobs, JL Anderson, N Albert ACCF/AHA Task Force Members 2011 ACCF/AHA/HRS focused update on the management of patients with atrial fibrillation (updating the 2006 guideline): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines Circulation 123 2011 104 123
100. SH Hohnloser, HJ Crijns, M van Eickels et al. Effect of dronedarone on cardiovascular events in atrial fibrillation N Engl J Med 360 2009 668 678
101. SJ Connolly, HJ Crijns, C Torp-Pedersen for the ATHENA Investigators Analysis of stroke in ATHENA: a placebo-controlled, double-blind, parallel-arm trial to assess the efficacy of dronedarone 400 mg BID for the prevention of cardiovascular hospitalization or death from any cause in patients with atrial fibrillation/atrial flutter Circulation 120 2009 1174 1180
102. BN Singh, SJ Connolly, HJ Crijns et al. Dronedarone for maintenance of sinus rhythm in atrial fibrillation or flutter N Engl J Med 357 2007 987 999 (Pubitemid 47367078)
103. J Le Heuzey, GM De Ferrari, D Radzik, M Santini, J Zhu, JM Davy A short-term, randomized, double-blind, parallel-group study to evaluate the efficacy and safety of dronedarone versus amiodarone in patients with persistent atrial fibrillation: the DIONYSOS study J Cardiovasc Electrophysiol 21 2010 597 605
104. JM Davy, M Herold, C Hoglund et al. Dronedarone for the control of ventricular rate in permanent atrial fibrillation: the Efficacy and safety of dRonedArone for the cOntrol of ventricular rate during atrial fibrillation (ERATO) study Am Heart J 156 2008 527.e1 527.e9
105. JP Piccini, V Hasselblad, ED Peterson, JD Washam, RM Califf, DF Kong Comparative efficacy of dronedarone and amiodarone for the maintenance of sinus rhythm in patients with atrial fibrillation J Am Coll Cardiol 54 2009 1089 1095
106. L Kober, C Torp-Pedersen, JJ McMurray et al. Increased mortality after dronedarone therapy for severe heart failure N Engl J Med 358 2008 2678 2687 (Pubitemid 351860860)
107. SH Hohnloser, HJ Crijns, M van Eickels for the ATHENA Investigators Dronedarone in patients with congestive heart failure: insights from ATHENA Eur Heart J 31 2010 1717 1721
108. SJ Connolly, AJ Camm, JL Halperin et al. Dronedarone in high-risk permanent atrial fibrillation N Engl J Med 2011 10.1056/NEJMoa1109867 published online Nov 14.
109. Food and Drug Administration FDA drug safety communication: severe liver injury associated with the use of dronedarone (marketed as Multaq) http://www.fda.gov/Drugs/DrugSafety/ucm240011.htm Jan 14, 2011 (accessed Oct 3, 2011).
110. MA Wood, C Brown-Mahoney, GN Kay, KA Ellenbogen Clinical outcomes after ablation and pacing therapy for atrial fibrillation: a meta-analysis Circulation 101 2000 1138 1144 (Pubitemid 30146615)
111. C Ozcan, A Jahangir, PA Friedman et al. Long-term survival after ablation of the atrioventricular node and implantation of a permanent pacemaker in patients with atrial fibrillation N Engl J Med 344 2001 1043 1051 (Pubitemid 32267974)
112. M Brignole, M Gammage, P Puggioni et al. Comparative assessment of right, left and bi-ventricular pacing in patients with permanent atrial fibrillation Eur Heart J 26 2005 712 722 (Pubitemid 40516884)
113. M Gasparini, A Auricchio, M Metra et al. Long-term survival in patients undergoing cardiac resynchronization therapy: the importance of performing atrioventricular junction ablation in patients with permanent atrial firillation Eur Heart J 29 2008 1644 1652 (Pubitemid 351957539)
114. D Yannopoulos, KG Lurie, S Sakaguchi et al. Reduced atrial tachyarrhythmia susceptibility after upgrade of conventional implanted pulse generator to cardiac resynchronization therapy in patients with heart failure J Am Coll Cardiol 50 2007 1246 1251 (Pubitemid 47405134)
115. M Gasparini, JS Steinberg, A Arshad et al. Resumption of sinus rhythm in patients with heart failure and permanent atrial fibrillation undergoing cardiac resynchronization therapy: a longitudinal observational study Eur Heart J 31 2010 976 983
116. MO Sweeney, AJ Bank, E Nsah et al. Search AV Extension and Managed Ventricular Pacing for Promoting Atrioventricular Conduction (SAVE PACe) Trial. Minimizing ventricular pacing to reduce atrial fibrillation in sinus-node disease N Engl J Med 357 2007 1000 1008
117. OM Wazni, NF Marrouche, DO Martin et al. Radiofrequency ablation vs antiarrhythmic drugs as first-line treatment of symptomatic atrial fibrillation: a randomized trial JAMA 293 2005 2634 2640 (Pubitemid 40744248)
118. C Pappone, G Augello, S Sala et al. A randomized trial of circumferential pulmonary vein ablation versus antiarrhythmic drug therapy in paroxysmal atrial fibrillation: the APAF Study J Am Coll Cardiol 48 2006 2340 2347 (Pubitemid 44856763)
119. P Jais, B Cauchemez, L Macle et al. Catheter ablation versus antiarrhythmic drugs for atrial fibrillation: the A4 study Circulation 118 2008 2498 2505
120. A Noheria, A Kumar, JV Wylie Jr, ME Josephson Catheter ablation vs antiarrhythmic drug therapy for atrial fibrillation: a systematic review Arch Intern Med 168 2008 581 586 (Pubitemid 351468392)
121. H Calkins, MR Reynolds, P Spector et al. Treatment of atrial fibrillation with antiarrhythmic drugs or radiofrequency ablation: two systematic literature reviews and meta-analyses Circ Arrhythm Electrophysiol 2 2009 349 361
122. JP Piccini, RD Lopes, MH Kong, V Hasselblad, K Jackson, SM Al-Khatib Pulmonary vein isolation for the maintenance of sinus rhythm in patients with atrial fibrillation: a meta-analysis of randomized, controlled trials Circ Arrhythm Electrophysiol 2 2009 626 633
123. GM Nair, PB Nery, S Diwakaramenon, JS Healey, SJ Connolly, CA Morillo A systematic review of randomized trials comparing radiofrequency ablation with antiarrhythmic medications in patients with atrial fibrillation J Cardiovasc Electrophysiol 20 2009 138 144
124. DJ Wilber, C Pappone, P Neuzil for the ThermoCool AF Trial Investigators Comparison of antiarrhythmic drug therapy and radiofrequency catheter ablation in patients with paroxysmal atrial fibrillation: a randomized controlled trial JAMA 303 2010 333 340
125. MR Reynolds, J Walczak, SA White, DJ Cohen, DJ Wilber Improvements in symptoms and quality of life in patients with paroxysmal atrial fibrillation treated with radiofrequency catheter ablation versus antiarrhythmic drugs Circ Cardiovasc Qual Outcomes 3 2010 615 623
126. J Dewire, H Calkins State-of-the-art and emerging technologies for atrial fibrillation ablation Nat Rev Cardiol 7 2010 129 138
127. R Cappato, H Calkins, SA Chen et al. Prevalence and causes of fatal outcome in catheter ablation of atrial fibrillation J Am Coll Cardiol 53 2009 1798 1803
128. F Ouyang, R Tilz, J Chun et al. Long-term results of catheter ablation in paroxysmal atrial fibrillation: lessons from a 5-year follow-up Circulation 122 2010 2368 2377
129. G Hindricks, C Piorkowski, H Tanner et al. Perception of atrial fibrillation before and after radiofrequency catheter ablation: relevance of asymptomatic arrhythmia recurrence Circulation 112 2005 307 313 (Pubitemid 41022070)
130. WD Johnson, AK Ganjoo, CD Stone, RC Srivyas, M Howard The left atrial appendage: our most lethal human attachment! Surgical implications Eur J Cardiothorac Surg 17 2000 718 722 (Pubitemid 30364952)
131. AS Kanderian, AM Gillinov, GB Pettersson, E Blackstone, AL Klein Success of surgical left atrial appendage closure: assessment by transesophageal echocardiography J Am Coll Cardiol 52 2008 924 929
132. RO Bonow, B Carabello, K Chatterjee et al. Guidelines for the management of patients with valvular heart disease: executive summary. A report of the American College of Cardiology/American Heart Association Task force on Practice Guidelines Circulation 114 2006 e84 231
133. PC Block, S Burstein, PN Casale et al. Percutaneous left atrial appendage occlusion for patients in atrial fibrillation suboptimal for warfarin therapy: 5-year results of the PLAATO (Percutaneous Left Atrial Appendage Transcatheter Occlusion) Study JACC Cardiovasc Interv 2 2009 594 600
134. DR Holmes, VY Reddy, ZG Turi for the PROTECT AF Investigators Percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial fibrillation: a randomised non-inferiority trial Lancet 374 2009 534 542